NewSpring, a Radnor, PA-based family of private equity strategies investing in the lower-middle market, raised over $180M for fourth growth equity healthcare fund, NewSpring Health Capital IV (“NSH IV”).
NewSpring Healthcare is a thesis-driven, domain-specific growth equity strategy, with over 20 years of experience investing in companies that help different segments of the healthcare ecosystem transform the way care is delivered to patients. NSH IV received support from existing and new investors, which include a diverse group of strategics, financial institutions, and family offices. Its team focuses on proprietary deal flow, using primary and secondary research to identify sectors that have a meaningful influence on healthcare.
NSH IV has already made six investments prior to the final close, including specialized pharmaceutical distribution services provider, AeroSafe Global; end-to-end sleep disorders management provider, BetterNight; cardiovascular staffing leader, Healthworks; mobile dysphagia diagnostics leader, Patheous Health; provider of business process outsourcing services to behavioral health programs, Prosperity Behavior Health; and industry leader in healthcare disclosure management technology and services, Verisma.
Founded in 1999, NewSpring manages approximately $3.5 Billion across five distinct strategies covering the spectrum from growth equity and control buyouts to mezzanine debt.